Narrative review / 2013
Curcumin is reviewed as an orally bioavailable, safe agent that blocks TNF-α action and production in vitro, in animals, and in humans.
This review evaluates curcumin, a component of turmeric, as an alternative to expensive injectable TNF-α blockers approved for inflammatory conditions. The authors report that curcumin is orally bioavailable and highly safe in humans, and can block TNF-α production and action across in vitro models, animal models, and human studies. Evidence is discussed regarding curcumin's activity against diseases treated with TNF blockers, along with mechanisms inhibiting TNF production and signalling pathways.
- Study type
- Narrative review
- Who was studied
- In vitro models, animal models, and humans
- What was measured
- Inhibition of TNF-α action and production, and effects on TNF-related diseases
THE PAPER
Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.
Aggarwal BB, Gupta SC, Sung B. Br J Pharmacol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.